Medpace Faces Securities Class Action as Law Firms Rally Investors

Overview

• Two shareholder-rights firms announced opportunities for Medpace investors to lead a securities class action, with a June 5, 2026 cutoff to contact them.
• The lawsuit alleges violations of federal securities laws based on claims that Medpace made false statements that lifted its share price.
• The complaint cites later disclosures showing a weaker book-to-bill ratio than expected, with cancellations at the highest level in over a year, noting book-to-bill compares new orders to work delivered.
• The proposed class period spans April 22, 2025 through February 9, 2026 for investors who bought Medpace shares in that window.
• The class has not been certified, so investors are not yet represented by counsel, and they can still share in any recovery without serving as lead plaintiff.